Boston Scientific (NYSE:BSX) announced today that it entered into an agreement to acquire Valencia Technologies for an undisclosed amount.

Boston Scientific is buying up privately owned medtech Valencia Technologies for its implantable device aimed at helping reduce the effects of overactive bladder disorder. | Boston Scientific is buying up privately owned medtech Valencia Technologies for its implantable device aimed at helping reduce the effects of overactive bladder disorder.

The FDA sent an early safety alert warning clinicians of deployment failures with certain Boston Scientific AXIOS Stent and Electrocautery Enhanced Delivery Systems that have been linked to three deaths and 167 serious injuries.

Valencia’s eCoin implantable tibial nerve stimulation (ITNS) system for urge urinary incontinence (UUI) treatment gained FDA approval in 2022.

Boston Scientific to buy Penumbra for $14.5B, expanding neurovascular thrombectomy, with long-term margin gains. Click here for more on BSX and PEN stocks.

At Boston Scientific, caring for human life is the common bond that connects our mission, business priorities and environmental, social and governance (ESG) strategy. As we grow to meet the increasing global demand for our products and deliver meaningful ...